Russia is seeking the partnership with India for producing COVID-19 vaccine ‘SputnikV’, The CEO of the Russian Direct Investment Fund (RDIF). Kirill Dmitriev, said on Thursday. Two weeks back, Russia announced the registration of the world’s first vaccine for coronavirus and the development was confirmed by President Vladimir Putin, who spoke about its efficacy and providing stable immunity. Addressing the press briefing, Dmitriev said several nations showed significant interest in the production of the vaccine including Latin America, Asia and the Middle East. However, the country is looking for a partnership with an Indian firm. As an advertisement,Dmitriev said”The production of vaccine is an important issue. Currently, we are looking for the partnership with India.Our belief is that India is capable of producing the Gamaleya vaccine and yes those partnerships to produce the vaccine will enable us to cover the demand that world have.”
The investment fund CEO also said that the country is looking forward to international cooperation for the same. The clinical trials for the Russian vaccine are also being conducted in the UAE, Saudi Arabia and most probably in Brazil as well as India, he added. Advertisement Russia has received high delivery demands from many countries and for the same, it is planning to produce the vaccine in more than five countries. More than 20,000 people have taken part in the clinical trials of vaccines and drugs, based on human adenoviruses or human adenoviral vectors, Alexander Gintsburg, the director of the Gamaleya Research Institute of Epidemiology and Microbiology informed the media. “The vaccines dont’ contain live human adenoviruses, but contain human adenovirus vectors, that is, human viruses that cannot multiply again in the body and they are completely safe,” Gintsburg as quoted. Gamaleya Institute has produced the vaccine in partnership with the Russian Defence Ministry. The vaccine still needs to conduct Phase 3 clinical trials.